Meloxicam;Le meloxicam

Revue Medicale de Bruxelles

Volumn 19, Issue 1, 1998, Pages 29-32

  Sternon, J ^a,b   Appelboom, Th ^a  

^a ERASME HOSPITAL   (Belgium)

^b Campus Facultaire d'Anderlecht ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; MELOXICAM; NABUMETONE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLACEBO; TENOXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ANKYLOSING SPONDYLITIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG SELECTIVITY; GASTROINTESTINAL TOXICITY; HUMAN; LIVER TOXICITY; MENTAL DISEASE; NEPHROTOXICITY; OSTEOARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; ARTHRITIS; BIOAVAILABILITY; DRUG INTERACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; ARTHRITIS, RHEUMATOID; BIOLOGICAL AVAILABILITY; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; HUMANS; SPONDYLITIS, ANKYLOSING; THIAZINES; THIAZOLES;

EID: 0031994822     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Malaise M : Les anti-inflammatoires non-stéroidiens. Rev Méd Liège 1996 ; 51: 123-5
2. Sternon J, Adler M : Les complications digestives et extra-digestives des anti-inflammatoires non stéroïdiens. Stratégies préventives et curatives. Rev Méd Brux 1997 ; 18 : 52-8
3. Wolfe MM : NSAIDs and the gastrointestinal mucosa. Hosp Pract 1996 ; 31 : 37-44, 47-8
4. Henry D, Lim L, Garcia Rodriguez LA et al : Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative metaanalysis. Br Med J 1996 ; 312 : 1563-6
5. Gabriel SE, Jaakkimainen L, Bombardier C : Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115 : 787-96
6. Richardson C, Emery P : The clinical implications of inhibition of the inducible form of cyclo-oxygenase. Drug Safety 1996 ; 15 : 249-60
7. Jouzeau JY, Terlain B, Abid A, Nédélec E, Netter P : Cyclooxygenase isoenzymes. Drugs 1997 ; 53 : 563-82
8. Flower R : The roles of Cox-1 and Cox-2: implications for NSAID development. Curr Opinion Rheumatol 1996 ; 8 (Suppl 1) : S9-S16
9. Hosie J, Distel M, Bluhmki E : Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium. Br J Rheumatol 1996 ; 35 (suppl 1) : 39-43
10. Barner A : Review of clinical trials and benefit/risk ratio of meloxicam. Scand J Rheumatol 1996 ; 25 (suppl 102) : 29-37
11. Lemmel EM, Bolten W, Burgos-Vargas R et al : Efficacy and safety of meloxicam in patients with rheumatoïd arthritis. J Rheumatol 1997 ; 24 : 282-90
12. Dougados M, Velicitat P, Veys E, Zeidler H, Calin A : Meloxicam in ankylosing spondylitis: a 6 weeks double-blind comparison with placebo and piroxicam (Abstract) - XIX Congrès de l'ILAR - juin 1997
13. Distel M, Mueller C, Bluhmki E, Fries J : Safety of meloxicam: a global analysis of clinical trials. Br J Rheumatol 1996 ; 35 (suppl 1) : 68-77
14. Bevis PJR, Bird HA, Lapham G : An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment. Br J Rheumatol 1996 ; 35 (suppl 1) : 56-60
15. Türck D, Su CAPF, Heinzel G, Busch U, Bluhmki E, Hoffmann J : Lack of interaction between meloxicam and warfarin in healtlhy volunteers. Eur J Clin Pharmacol 1997 ; 51 : 421-5
16. Hübner G, Sander O, Degner FL, Türck D, Rau R : Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis. J. Rheumatol 1997 ; 24: 845-51
17. Hayllar J, Bjarnason I : NSAIDs, Cox-2 inhibitors, and the gut. Lancet 1995 ; 346 : 521-2
18. Bennett A, Tavares IA, Vane JR : NSAIDs, Cox-2 inhibitors. and the gut. Lancet 1995 ; 346 : 1105-6
19. Battistini B, Botting R, Bakhle YS : COX-1 and COX-2: Toward the development of more selective NSAIDs. Drug News & Prospect 1994 ; 7 : 501-12
20. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL : Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Experiment Ther 1994 ; 271: 927-34
21. Editorial : Meloxicam. Revue Prescrire 1997 ; 173 : 321-4